Quantcast
Channel: Форумы для людей с аутоиммунными заболеваниями
Viewing all articles
Browse latest Browse all 8890

GSK's Crohn's disease treatment fails in Phase III trial

$
0
0
British pharmaceutical group GlaxoSmithKline Plc said vercirnon, a drug it was developing to treat Crohn's disease and licensed from ChemoCentryx, had failed in a late-stage clinical trial.


More...

Viewing all articles
Browse latest Browse all 8890

Trending Articles